0.2527
price up icon30.28%   0.0587
after-market Handel nachbörslich: .27 0.0173 +6.83%
loading
Schlusskurs vom Vortag:
$0.194
Offen:
$0.2059
24-Stunden-Volumen:
15.09M
Relative Volume:
1.71
Marktkapitalisierung:
$10.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.71M
KGV:
-0.0216
EPS:
-11.71
Netto-Cashflow:
$-18.24M
1W Leistung:
+24.94%
1M Leistung:
-13.35%
6M Leistung:
-4.44%
1J Leistung:
-26.05%
1-Tages-Spanne:
Value
$0.2001
$0.259
1-Wochen-Bereich:
Value
$0.17
$0.28
52-Wochen-Spanne:
Value
$0.14
$3.97

Genprex Inc Stock (GNPX) Company Profile

Name
Firmenname
Genprex Inc
Name
Telefon
512-537-7997
Name
Adresse
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Name
Mitarbeiter
15
Name
Twitter
@genprex
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GNPX's Discussions on Twitter

Vergleichen Sie GNPX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GNPX
Genprex Inc
0.2527 8.32M 0 -22.71M -18.24M -11.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Genprex Inc Stock (GNPX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-01-26 Eingeleitet National Securities Buy
2019-04-29 Eingeleitet Noble Capital Markets Outperform

Genprex Inc Aktie (GNPX) Neueste Nachrichten

pulisher
07:56 AM

Pre-market Movers: GNPX, BFRI, DBVT See Big Swings - RTTNews

07:56 AM
pulisher
07:09 AM

Why Genprex Inc. stock is popular among millennials2025 Price Momentum & AI Enhanced Trading Alerts - newser.com

07:09 AM
pulisher
07:00 AM

10–33x tumor uptake: Genprex's REQORSA shows targeted TUSC2 delivery in preclinical poster on Oct 25 - Stock Titan

07:00 AM
pulisher
04:08 AM

Using portfolio simulators with Genprex Inc. includedMarket Risk Summary & Technical Buy Zone Confirmations - newser.com

04:08 AM
pulisher
02:29 AM

What institutional flow reveals about Genprex Inc.Weekly Trend Report & Daily Technical Forecast Reports - newser.com

02:29 AM
pulisher
02:21 AM

How Genprex Inc. stock responds to policy changesMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com

02:21 AM
pulisher
Oct 13, 2025

Will Genprex Inc. stock deliver consistent dividendsWeekly Trend Summary & Community Supported Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to forecast Genprex Inc. trends using time seriesPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com

Oct 13, 2025
pulisher
Oct 09, 2025

Heatmap analysis for Genprex Inc. and competitorsJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What to expect from Genprex Inc. in the next 30 daysJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Genprex Inc. still worth holding after the dipQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

How high can Genprex Inc. stock goMarket Movers & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Genprex Inc. stock resist market sell offsJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Genprex Inc. (2DE0) stock a top hedge fund pickTrade Entry Report & High Conviction Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Analyzing net buyer seller activity in Genprex Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Risk vs reward if holding onto Genprex Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - FinancialContent

Sep 30, 2025
pulisher
Sep 30, 2025

Is Genprex Inc a good long term investmentDividend Stock Watch & Superior Wealth Strategies - earlytimes.in

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Genprex Inc stockRetail Investor Activity & Invest Now – Opportunity Window Closing - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What drives Genprex Inc 2DE0 stock priceIPO Market Watch & Claim Your Custom Stock Report Now - earlytimes.in

Sep 27, 2025
pulisher
Sep 27, 2025

Using economic indicators to assess Genprex Inc. potentialEarnings Recap Report & Low Risk Entry Point Tips - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Genprex Inc stock priceTechnical Breakout Signals & Free Trading Signals to Sharpen Your Edge - Early Times

Sep 27, 2025
pulisher
Sep 20, 2025

What the charts say about Genprex Inc. today2025 Technical Overview & Reliable Volume Spike Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Does Genprex Inc. fit your quant trading modelTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com

Sep 20, 2025

Finanzdaten der Genprex Inc-Aktie (GNPX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):